MyCelx Technologies Corporation Project Award
29 Ottobre 2024 - 8:00AM
RNS Regulatory News
RNS Number : 9442J
MyCelx Technologies Corporation
29 October 2024
The information
contained within this Announcement is deemed by MYCELX Technologies
Corporation to constitute inside information as stipulated under
the Market Abuse Regulation (EU) No. 596/2014 as it forms part of
UK domestic law by virtue of the European Union (Withdrawal) Act
2018 ("MAR").
29 October
2024
MYCELX Technologies
Corporation
("MYCELX" or the
"Company")
Project Award
MYCELX Technologies Corporation (AIM: MYX), the
clean water and clean air technology company, is pleased to
announce the award of a project which represents the Company's
second REGEN installation at a Middle East Producer to treat
produced water during Enhanced Oil Recovery ("EOR") production.
This contract follows on the successful installation of our
proprietary REGEN Retro-fit package that was delivered in April of
this year.
The value of the project is c.$1.5 million and
helps to underpin the Company's 2025 revenue forecast. This
contract further solidifies MYCELX's industry-leading position in
ensuring improved production performance and reliability as well as
providing better water management and water savings during EOR
production. The Company looks forward to working closely with the
client as they continue to upgrade and expand their assets as well
as with other producers in the region who collectively operate
multiple production fields.
Connie Mixon,
CEO, commented:
"We are
pleased to have secured another project with this leading Middle
East Producer, which supports our view that the EOR production
market will deliver significant growth opportunities for the
business. These project wins highlight our strong technical
position in produced water treatment where conventional methods of
treatment are struggling to meet the needs of advanced oil
production methods. We look forward to providing investors with
further updates as we move towards year-end and into
2025."
For further information, please
contact:
MYCELX
Technologies Corporation
Connie Mixon, CEO
Kim Slayton, CFO
|
Tel: +1 888 306 6843
|
Canaccord
Genuity Limited (Nominated Adviser and Sole
Broker)
Henry Fitzgerald-O'Connor
Charlie Hammond
Sam Lucas (ECM)
|
Tel: +44 20 7523 8000
|
Celicourt
Communications (Financial PR)
Mark Antelme
Jimmy Lea
Charlie Denley-Myerson
|
Tel: +44 20 7770 6424
|
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
STRUWVWRSSURUAA
Grafico Azioni Mycelx Technologies (LSE:MYX)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni Mycelx Technologies (LSE:MYX)
Storico
Da Nov 2023 a Nov 2024